As china takes a larger presence in the world, Chinese traditional medicine-a treasury of Chinese tradition-has drawn a broad attention.By referring to various traditional medicine literature, combined with years of experience at pharmaceutical companies, the author reviews china’s pharmaceutical/traditional medicine industry and operations of Inner Mongolian Datang Pharmaceutical Enterprise. In addition, the author suggests Datang adopts a refined corporate strategy focusing on authentic Mongolian medicine and expand along the whole value chain.First, the author talks about China’s pharmaceutical industry, the development of traditional medicine such as Tibetan and Miao medicine, the gap in growth between Mongolian and other ethnical medicine, as well as government guidance and support.Secondly, the author reviews the history and current operations of Inner Mongolian Datang Pharmaceutical Enterprise and concludes that the biggest problem in the company is a lack of clearly defined corporate strategy, by utilizing Porter’s five forces analysis on its all product lines.Third, based on SWOT analysis on Mongolian medicine prospect and industry knowledge sharing, the author decides that authentic Mongolian medicine should be the company’s strategic focus.Lastly, the author elaborates on the execution of this new strategy, to name a few, establishing International Institute of Mongolian Medicine, re-enabling of century-old brand, introducing new products, integrating medicine plantation base, conducting Mongolian medicine research and scalable plantation, collecting authentic medicine plant sample, building up testing pad, sample complex, etc. |